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Introduction
Behavioral factors are hypothesized to influence the immune
system, with implications for infectious disease risk (1–3). Other
studies have found that older adult populations show a substan-
tial decline in immune function and are at increased risk for a
number of infectious diseases (4,5). Taken together, the unto-
ward effects of age and behavioral symptoms (e.g. depressed
mood or insomnia) raise the question of whether behavioral
interventions might augment immune responses in older adults
who may be risk for a decline of viral-specific immunity. In this
review, we focus on an infectious disease model related to reac-
tivation of a latent herpes virus, varicella zoster virus (VZV);
examine the risk factors associated with the increased incidence
of herpes zoster (HZ) in older adults; discuss the psychosocial
influences that may modulate VZV-specific immunity in older
adults; and report on the use of a mind–body, behavioral inter-
vention to ameliorate these risk factors.
Herpes Zoster
HZ or shingles is caused by reactivation of an endogenous VZV
infection that has persisted in a latent form within sensory
ganglia following an earlier attack of varicella (chickenpox) (6).
Both the incidence and severity of HZ increase markedly with
increasing age, and the majority of episodes occur in persons
over the age of 60 years (7,8). At age 50, the annual incidence
of HZ is 2.5–4.0 cases per 1000; this rate nearly doubles by the
age of 60 years, HZ afflicts more than 500 000 persons per year
in the USA (8).
HZ and VZV-specific Immunity
The factors associated with increased risk of HZ in the older
adult and the mechanisms responsible for maintaining VZV in
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much circumstantial evidence that cell-mediated immunity
plays a critical role in limiting the occurrence of HZ and its
complications (6,9,10) (Fig. 1). Age-related decline in VZV-
responder cell frequency (RCF; frequency of lymphocytes that
proliferate in response to VZV antigen) is temporally related
to an increase in the incidence and severity of HZ and its
complications in older rats (7,8,11–14). Further, iatrogenic
immunosuppression with diminished VZV-specific T-lympho-
cyte proliferation is associated with greater susceptibility to
VZV reactivation and HZ (15–17). In contrast to the age
related decline of cellular immunity, levels of antibodies to
VZV do not appear to be significantly diminished in the
elderly, nor is there any increased frequency of HZ in individ-
uals who lack VZV antibodies (i.e. patients with congenital or
acquired  -globulin deficiencies) (6,18). Moreover, in elderly
subjects, there is no decline in the number of memory
CD45RO  T cells, a finding that argues against the selective
loss of this subset as the cause of decline in VZV-RCF with
age (19). The proliferative response to VZV is confined to
CD4  CD45RO  T cells in the assay of VZV-RCF; the number
of antigen-presenting cells is not limiting (11).
Individual Variability in VZV-specific Immunity
and the risk of HZ
It has been hypothesized that HZ does not occur at random in
older adults, but rather selectively strikes individuals whose cell-
mediated immunity to VZV is reduced (14) (Fig. 2). Older adult
populations are very heterogeneous with respect to baseline
VZV-specific in immunity as well as other aspects of cellular
immunity (20). Moreover, we have found that the immunologi-
cal response to varicella zoster vaccine is variable and not
universal. The factors that account for this variability, selective
response to immunization and altered risk for HZ in older adults
are not well understood, but within-population differences in
physical and psychological functioning have been implicated.
Depressive Symptoms, Health Behaviors and
VZV-specific Immunity in the Older Adult
In view of recent evidence that the immune system is integrated
with other homeostatic processes ultimately regulated by the
brain (1,2) (Fig. 3), the influence of biobehavioral factors on
the incidence of HZ and on VZV-specific immune responses
deserves attention. Thus, we have examined the effects of major
depression on VZV-specific immunity by comparing VZV-RCF
levels in middle-aged depressed patients versus controls who
were matched on the basis of age and gender (21). All subjects
were in good physical health and none were receiving
psychotropic medications or other treatments that are known to
alter immune responses. VZV-RCF was significantly lower in
the subjects with major depression than in matched normal
controls, indicating that depression and possibly other behav-
ioral factors such as disordered sleep (22) are associated with a
marked decline in VZV-specific cellular immunity, as measured
by the frequency of peripheral blood mononuclear cells capable
of proliferating in response to VZV antigen.
In the older adult, other factors such as the presence of
chronic disease, increased risk of exposure to stressful life
events and personal losses, diminished social supports and
declines of self-concepts of efficacy and mastery might also
impinge on immune defences and increase the risk of HZ and
possibly other infectious diseases (3,23). However, there are
few clinical data that have addressed the confluence of behav-
ioral, immunological and health outcome variables in the same 
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Figure 1. Varicella zoster virus specific cellular immunity and age. The relationship between human age, level of lymphocyte proliferative response to varicella
zoster virus antigen and phytohemagglutinin (PHA), and delayed-type hypersensitivity response to varicella zoster virus antigen skin challenge. There is a marked
attenuation of varicella zoster-specific cellular immunity in persons over the age of 60 years. Reprinted from Burke et al. (13).individuals at the same time, despite the promise of animal
studies showing a link between behavioral stressors and viral
infectious disease susceptability (24,25). In humans, psychoso-
cial stress (e.g. caregiving for an ill relative or marital distress)
is reported to correlate with reduced immunological control of
latent herpes viruses [Epstein–Barr virus (EBV), herpes simplex
virus (HSV) and cytomegalovirus (CMV)], as evidenced by
elevated antibody titers and reduced memory T-cell responses
(26–28). In addition, beyond the effects of chronic stress on
latent herpes viral models, perceived life stress correlates with
increased rates of respiratory infection after experimental
inoculation with common cold viruses (29,30) and with
decreased immunological responses following vaccination
against hepatitis B (31). However, no studies have examined
the relationship between behavioral factors and HZ other than
the retrospective and prospective analyses of Schmader et al.
(32–34). In the first study, 101 individuals with recent HZ
reported a significantly higher number of stressful, and partic-
ularly ‘negative’ life events, in the 6 months before rash onset
compared with 101 age-matched controls (34). The second
study involving 2568 persons found that negatively perceived
events were modestly associated with an increased risk of
zoster over 8 years of follow-up (33). Another recent study
reported that space flight was associated with increases of viral
reactivation and shedding into saliva (35). In older adults, who
are on average at increased risk for infectious disease due to
age-related declines of immune function, the link between
psychosocial factors, immunity and infectious disease outcomes
is relatively unexplored apart from the observations of Kiecolt-
Glaser et al. and Vedhara et al., who found that Alzheimer
caregiver stress depresses cellular immune responses to
influenza vaccination (36,37). If the decline of immunity to
VZV and the increased risk of HZ in older adults were shown
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Figure 2. Pathogenesis of herpes zoster. Reprinted with
permission from Oxman (111).
Figure 3. Relationship between depression, life stress, sleep and the autonomic,
neuroendocrine and immune systems. The evidence for the relationship between
life stress and depression and varicella zoster-specific immunity and herpes
zoster risk is the subject of this review. Possible mechanisms for these effects
including alterations in behavioral responses such as disordered sleep or abnor-
mal activation of the sympathetic nervous system are also considered.to be related psychosocial factors alone or in combination with
the effects of age and chronic disease, this could provide
invaluable insight into the biobehavioral mechanisms of
immune changes in older adults and these insights could refine
behavioral strategies for amelioration of these immune effects.
Biological and Behavioral Changes in the
Older Adult: Implications for Declining 
Immune Responses
Older adults are at increased risk for infectious and inflamma-
tory disorders (38), which is thought to be due at least in part to
autonomic and behavioral abnormalities associated with aging
(39) (Fig. 3). In addition, stress may compound these abnor-
malities in older adults (40,41). Aged organisms show an exag-
gerated autonomic and neuroendocrine responsivity to stress in
which responses are delayed in shutting off, with attendant sup-
pressive effects on natural and cellular immunity (42). Likewise,
depressed and/or psychologically stressed persons show eleva-
tions of sympathoadrenal activity at rest and in response to acute
challenge; such cardiovascular and sympathetic abnormalities
correlate with many of the immunological changes found in
these populations (43,44). Other studies on behavioral mecha-
nisms suggest that sleep disturbance uniquely contributes to the
multi-system physiological effects of aging, stress and affective
disorders (22,45). Sleep disturbance, prominent in older adults,
results in sympathoadrenal activation (46) and is associated with
declines in immune function (47–49) (Fig. 3).
Successful Adaptation: Role of Psychological
and Behavioral Interventions
Psychobiological models posit an inter-relationship between
aging, stressor, cognitive appraisal of stress, affective integra-
tion and translation of the cognitive and affective processes
into changes in immunity and HZ risk. However, feedback
systems are also operative to VZV. Not only can one’s
appraisal of stressors elicit affective and physiological arousal
but, conversely, physiology can influence one’s thinking (23).
Consequently, several strategies for intervention can be deduced
from consideration of a reciprocal interaction between mind–
brain–body. One approach involves modifying cognitive 
appraisal and ameliorating emotional distress (e.g. cognitive–
behavioral therapy), whereas another focuses on reducing
psychophysiological arousal through the use of relaxation
response-based training. In a model that is reciprocal, the
causal priority of the intervention is less of a concern than the
view that effective stress management is related to its impact
on the interaction of cognitions, affective responses, physio-
logical activity and behavior (50).
As reviewed by Miller and Cohen (51), few studies have
reported on the effects of behavioral interventions on cellular
immunity. As an example, four studies have evaluated the
immune effects of hypnosis and relaxation (5,52–54). In two
of these studies, medical students were assigned randomly to a
hypnotic/relaxation group prior to examination stress (52,53).
Both studies found that the frequency of relaxation correlated
with an amelioration of stress-induced changes in lymphocyte
proliferation, natural killer (NK) cell activity and T-cell subset
enumeration, although neither study found significant effects
for the intervention due in part to variability in the practice of
relaxation. In older adults, progressive muscle relaxation
training was also found to produce significant increases in NK
cell activity and decreases in HSV antibody titers (5). Other
behavioral intervention studies have focused on development
of supportive social relationships, education and cognitive
re-appraisal of events. In patients with malignant melanoma,
supportive group psychotherapy was associated with increases
in NK cell activity that correlated with lower rates of recurrence
in a 6 year follow-up (55). In homosexual men and women
undergoing human immunodeficiency virus (HIV) antibody tes-
ing, omnibus cognitive–behavioral interventions were reported
to show increases of CD4 T lymphocytes and NK cells and
decreases in EBV and human herpesvirus type 6 antibody titers
(56). Finally, one study showed that simple emotional disclosure
enhanced the immune response to hepatitis B vaccination (57).
Limitations of Prior Behavioral Intervention
Strategies in Psychoneuroimmunology
Taken together, these data suggest that behavioral interventions
impact immune system functioning. However, there are several
limitations. Much more is known about the role of behavioral
factors in the suppression of immunity than about what behav-
ioral strategies may be important in boosting immune function,
especially in those at-risk populations who are aged, undergo-
ing stress or suffering from chronic disease. Secondly, in many
of the studies, standardization of techniques and/or participant
adherence (i.e. frequency of relaxation practice) was variable or
incompletely assessed. Thirdly, immunological outcomes (e.g.
non-specific lymphocyte proliferation) typically relied on
measures that were non-specific and for which clinically relev-
ant disease end-points had not been determined (58).
Tai Chi: Effects on Health Outcomes and 
HZ Immunity
Increasing interest has focused on the use of tai chi for
promoting health in persons with chronic disease (59–61), and a
recent review suggested the promise of tai chi as a means of
improving a number of health outcomes (59). However, the
majority of studies did not use randomized control trial method-
ologies, and the efficacy of tai chi on physiology and health
outcomes remains poorly characterized (59). Nevertheless, some
trials suggest that tai chi can improve health functioning, have
effects on both physical and emotional health (62), reduce the
risk of falls (63–65) and possibly enhance cardiovascular func-
tioning in sedentary and older adults (62,66–69). Randomized,
controlled trials are needed to test the effects of this novel
behavioral intervention on specific immunity and infectious
disease risk in vulnerable older adult populations.
226 Tai chi chih as a behavioral treatmentTai chi offers special promise as a mind–body intervention
that might enhance immune and health outcomes in older
adults, because it incorporates elements of meditation and
physical activity, both of which have been found to have
salutary effects on immune responses (40). Our laboratory has
proposed recently that tai chi chih (TCC), a westernized
version of tai chi, might be particularly suitable for evaluation
in randomized controlled trials (70), as TCC is a standardized
series of 20 simple, repetitive non-strenuous movements. TCC,
a form of ‘meditation through movement’, involves a series of
fluid, continuous forms of movement which are integrated by
mind concentration, balance and shifting of body weight,
muscle relaxation and breathing control. Because of its moder-
ate intensity, steady rhythm and low physical and mental
tension, TCC has been suggested as an appropriate intervention
for elderly patients (64) who are not otherwise able to adhere to
physical exercise. TCC incorporates physical activity, the main-
tenance of which predicts better physical performance, lower
frequency of health conditions and lower risk of functional
declines and mortality in older adults (71–73), possibly by on
reducing autonomic and inflammatory responses to challenge
(74–77). In this review, we discuss our recent findings that this
‘meditation through movement’ has immunological effects. In
a controlled trial, we assessed the effects of TCC on clinically
relevant immunity to VZV in older adults who were random-
ized to either TCC or a waiting list control group (70).
The study sample included 36 adults older than 60 years
of age, all of whom were in good health; 18 persons were
randomly allocated to the TCC group and 18 persons were
allocated to the waiting list control group. Randomization pro-
cedures were successful in delineating two groups of subjects
who were similar in age, gender, ethnicity, marital status,
current employment status and educational level. Inclusion
criteria were as follows: 60 years of age or older at time of
entry, geographically accessible, history of varicella (chicken-
pox) and long-term ( 30 years) residence in the continental
USA. The latter two inclusion criteria are indicative of the
prior occurrence of varicella and the potential for a specific
immunological memory response to VZV as measured by
VZV-RCF (78,79). Exclusion criteria were as follows:
immunosuppression resulting from neoplastic disease, corti-
costeroids or other therapy; significant underlying illness that
would be expected to prevent completion of the study; any
other condition (e.g. extensive psoriasis, chronic pain syndrome,
cognitive impairment or severe hearing loss) that in the
opinion of the investigator might interfere with the required
evaluations; not ambulatory; prior HZ; receipt of immuniza-
tions (e.g. hepatitis B vaccine or influenza vaccine) within 1
month of study entry; current depression, suicidal risk, use of
mood-altering medications or a combination of these depres-
sive factors; any acute intercurrent illness that might interfere
with interpretation of the study (such as an acute viral illness
within the last 2 weeks); and unable to commit to the inter-
vention schedule. Women were post-menopausal.
Subjects in the TCC group learned to perform 20 standardized
movements during a 15 week intervention period under the
guidance of an expert TCC teacher who had 20 years of expe-
rience in teaching this mind–body intervention. TCC is per-
formed as slow, relaxed, continuous movements incorporating
elements of balance, postural alignment and concentration.
It also requires a considerable amount of work by the leg
muscles and thus is thought to have an aerobic component of
moderate intensity (67). Thus, each TCC session was restricted
to 45 min with a 10 min warm-up, a 30 min TCC practice and
a 5 min cool-down period. Sessions were given three times per
week (45 sessions over 15 weeks). The level of participation in
the TCC was high, with median compliance at 39 of 45 possi-
ble sessions with a range of 29–42 sessions attended.
Participants assigned to the waiting list control group were
instructed to maintain their routine activities and not to begin
any new meditation, mind–body (e.g. yoga) or exercise pro-
grams; adherence was confirmed by self-report. The control p-
articipants were promised a TCC program and given a voucher
for instruction at the end of the study.
The results of this randomized controlled trial showed that
shingles immunity, as measured by VZV-RCF, increased from
baseline to 1 week post-intervention in the TCC intervention
group whereas the wait list control group did not change
significantly (Fig. 4). This effect of TCC was tested statistically
using a conservative intent-to-treat approach. To provide a
further indication of the effects of the intervention on VZV-
RCF, percentage change from baseline to post-intervention was
examined in individual subjects. Within the TCC intervention
group, VZV-RCF increased in nine subjects, was unchanged in
seven (including four who were analyzed as intent-to-treat cases)
and decreased in one subject; whereas in the control group, three
subjects increased, eight were unchanged (one intent-to-treat
case) and five decreased (likelihood ratio   6.1, P   0.05).
Importantly, the TCC group showed a robust increase of 
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Figure 4. VZV-specific CMI (VZV-RCF) at baseline and at 1 week post-
intervention in the intent-to-treat sample. VZV-RCF increased from baseline
to 1 week post-intervention in the TCC group [F(1,31)   4.4, P   0.05]
but not in the control group. Data are mean   SEM values. Reprinted with
permission from Irwin et al. (70).VZV-RCF, and on average had a nearly 50% increase of VZV-
RCF from baseline to 1 week post-intervention using this intra-
subject approach. In response to vaccination with live attenuated
Oka/Merck varicella vaccine, Levin et al. have demonstrated an
~75% increase above baseline in  200 seropositive elderly
adults (mean age 67 years) (80,81), an increase that is similar
to that induced by an episode of HZ (82). Response to vaccina-
tion is sustained for months to years (82), but further research is
needed to evaluate the durability of the effects of TCC on VZV-
RCF levels. Increases of VZV-RCF are driven primarily by the
response of CD4  CD45RO  T cells or memory T cells (83),
and we speculate that TCC might have comparable effects on
these cell types across the full spectrum of antigenic challenge,
with potential implications for multiple infectious diseases for
which no vaccine is yet available (e.g. HIV infection; respira-
tory infection). Moreover, the increase of VZV-RCF in this
sample is even more striking because the older adults were in
good health, not depressed and had higher baseline levels of
VZV-RCF than had been reported previously in this at-risk
population (84). Future studies could extend these findings and
examine the effects of TCC on other memory T-cell responses
(e.g. to influenza virus) and/or test whether this mind–body treat-
ment alters response to a primary immunological response.
Smith et al. have found that psychological stress impairs devel-
opment of a delayed-type hypersensitivity response to a novel
protein antigen, keyhole limpet hemocyanin, in humans (85),
whereas older adults who are more physically active show
higher antibody and delayed-type hypersensitivity responses to
this antigen as compared with sedentary older adults (86).
These data showing an increase of VZV immunity following
TCC contrast with those of Locke et al. who found that hypno-
sis had no effect on varicella antigen-induced delayed-type
hypersensitivity responses in humans (87).
It is thought that an increase in VZV-RCF may be associated
with better control of latent VZV virus, an assumption that has
led to the development of a varicella vaccine that induces
increases of VZV-RCF in older rats (82). In an ongoing
Veterans Affairs Cooperative Trial (n   38 546), this investi-
gational varicella zoster vaccine is currently being tested to
determine its efficacy in the prevention of onset and severity of
HZ and postherapetic neuralgia. The present TCC study does
not have an adequate sample size to address whether TCC can
alter the incidence of shingles, given its annual incidence at
 8 cases per 1000 persons. Alternatively, it is possible that the
increase of VZV-RCF associated with TCC might be second-
ary to viral reactivation. Mehta et al. recently reported that
non-surgical stress induces subclinical reactivation of VZV as
evidence by the detection of VZV DNA by polymerase chain
reaction in saliva samples, although no change in the levels of
anti-VZV IgG was found before and after the stress. Others
indicate that viral reactivation and shedding of VZV occur HZ
clinical outbreak (88) and/or zoster sine herpete (pain without
rash) (89,90), in contrast to mucosal shedding of other herpes
viruses that continues for decades after primary infection (91).
Importantly, none of our subjects evidenced HZ or reported
symptoms of pain or distress during the course of the trial.
Nevertheless, even if the intervention acts to induce subclini-
cal reactivation, increases of VZV-RCF, induced by contained
reversions may help to maintain immunity to VZV in older
adults and prevent future occurrences of HZ in older adults, as
suggested by Hope-Simpson (see Fig. 2) (14).
This study also found that TCC was associated with
improvements in physical functioning and physical role limi-
tations, especially in those older adults who had impairments
in physical status at entry. In the sample who completed the
intervention, the TCC group had significantly higher scores
on the Medical Outcomes Scale, SF-36 role-physical scores
(Fig. 5) and physical functioning scores at 1 week post-
intervention as compared with controls. Moreover, in those
older adults whose baseline scores were at or below the popu-
lation norm for men and women aged 60 years and older (92),
these observations were particularly striking. After completion
of the intervention, TCC participants showed increases of
health functioning scores to levels that were at or above the
population norms. Moreover, those participants who had low
health functioning at baseline showed more marked improve-
ments over time with significantly greater increases of SF-36
role-physical and physical functioning as compared with
changes in the TCC group who had minimal impairments of
physical status at baseline. The magnitude of change from
baseline to post-intervention was large for these measures of
health functioning and was comparable with that reported for
certain medical procedures. For example, in the instance of
SF-36 role-physical scores, the average change in the low TCC
group was comparable with or exceeded that reported for hip
replacement surgery (93) or for heart valve replacement in
older adults (94), although it is not known whether the effects
of TCC persist in the long term.
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Figure 5. SF-36 scale score role-physical at baseline, during the itnervention at
weeks 5, 10 and 15, and 1 week post-intervention in the completer sample, TCC
(n   14) and control group (n   17). SF-36 role-physical scores were higher in
the TCC group compared with controls [F(1,28)   5.1] at post-intervention.
Data are mean   SEM scores. Reprinted with permission from Irwin et al. (70).Several pathways may mediate the effects of TCC on immun-
ity and health functioning. Although none has yet been estab-
lished, we have hypothesized that two components, relaxation
and exercise, may mediate the observed changes in immunity
and health outcome (Fig. 6). In a meta-analyses on the effects of
relaxation training, Hyman et al. (95) found that various relax-
ation response-based interventions led to a reduction of clinical
somatic symptoms with additional effects on symptoms of anxi-
ety and depression (96), blood pressure (97) and recovery from
immune-mediated diseases such as psoriasis (98). Decreases of
autonomic arousal that follow relaxation-based interventions,
and possibly TCC, may modulate immunity. Substantial evid-
ence suggests that sympathetic activation has inhibitory effects
on cellular immune responses in the elderly (99–102), whereas
decreases of sympathetic outflow, adrenergic receptor antago-
nism, or both abrogate stress-induced immune suppression
(99,101,103,104). In contrast, TCC might increase parasympa-
thetic, vagally mediated tone which has been found to inhibit
proinflammatory cytokine mechanisms (105,106). Importantly,
the effects of TCC were not mediated by social functioning,
mental health functioning or changes in physical health status, as
the intervention did not alter SF-36 measures of social function-
ing or role-emotional, and SF-36 scores of physical functioning
were not correlated with changes in VZV-RCF.
The benefits of exercise and exercise training on immunity in
the elderly have been reported previously (107,108) and, as
noted above, physically active older adults have more robust
primary humoral and delayed-type hypersensitivity responses
to a novel antigenic challenge (86). In addition, moderate exer-
cise training for 8 weeks has been found to promote increases
of herpes viral-specific immunity in mice (109) and this effect
is mediated by adrenergic receptor mechanisms (110). Indeed,
TCC is a multifaceted intervention that includes not only relax-
ation, but also components of aerobic exercise (61,66). During
the acute practice of TCC, for example, increases of heart rate,
oxygen consumption and lactate accumulation are reported,
indicating that TCC serves as an aerobic exercise of moderate
intensity (66). Further data show that TCC training over 12
months enhances cardiorespiratory function as measured by
increases of VO2 MAX and decreases of blood pressure (68).
TCC Boosts Immunity to VZV and 
Health Status in Older Adults: Need for
Further Trials
Our research shows that an alternative medicine, mind–body
intervention, namely TCC, results in improvements in meas-
ures of immunity to VZV in an older adult population at risk for
HZ. TCC is a standardized and manualized series of exercises
that can be readily administered in a group setting to older
adults with cost-effectiveness, supporting the exportability of
this intervention for community-dwelling older adults. In addi-
tion, this study indicates that TCC has value for improving
functional limitations in physical domains. Other forms of tai
chi are purported to have physiological and psychological
benefits and to promote balance control and cardiovascular
fitness in older adults. Further high quality, randomized con-
trolled trials are needed to further delineate the effects of these
mind–body practices on health risk factors and on chronic med-
ical outcomes, especially in vulnerable older adult populations.
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